Document is current
Any future updates will be listed below
-
Authors
Fang, Corey https://orcid.org/0009-0005-9944-8626
Dobie, Casey
Ketkar, Amita
Verduzco-Gutierrez, Monica
Fadda, George
Bocage, Claire
Teng, Chia Chen Jenny
Perez, Raven
Brunk-Grady, Mark
Glasser, Lisa
Dube, Christine
Breslin, Nadine
Willey, Vincent
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 17 April 2025
First Online: 4 June 2025
Declarations
:
: Christine Dube, Nadine Breslin, Lisa Glasser, and Corey Fang are employees and shareholders of AstraZeneca. Monica Verduzco-Gutierrez has received honoraria and travel to give lectures related to long COVID-19; unrelated to this work, she has been a consultant with AbbVie (consultant/advisor, speakers bureau), Merz (consultant/advisor, speakers bureau), Ipsen (grant/research, consultant/advisor, speakers bureau), Medtronic (consultant/advisor), and Piramal (speakers bureau). George Fadda has been a consultant/advisor for AstraZeneca. Carelon Research received funding from AstraZeneca to conduct this study. Amita Ketkar, Vincent Willey, Raven Perez, Mark Brunk-Grady, Claire Bocage, and Chia-Chen Teng are employees of Carelon Research. Amita Ketkar, Claire Bocage, and Vincent Willey are shareholders of Elevance Health, which is the parent company of Carelon Research. Casey Dobie is an employee of Cencora Inc. and a consultant for AstraZeneca.
: Ethics committee approval was not required for this study. All data were accessed as a limited data set for which a business associate and data use agreement was in place with the covered entities in compliance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. All protected health data were deidentified and thus exempt from Institutional Review Board (IRB) review.
